Medacta received FDA 510(k) clearance and completed first knee revision procedures with 3DMetal™ Tibial Cones. The cones—and Medacta’s recently-announced shoulder system—are slated for 1Q18 launch.
The devices, created with the company’s 3D-printed biomaterial, can offer structural support in deficient bone, and are indicated for use with GMK Revision and GMK Hinge knees as well as the tibial extension stems and offset.
Medacta received FDA 510(k) clearance and completed first knee revision procedures with 3DMetal™ Tibial Cones. The cones—and Medacta's recently-announced shoulder system—are slated for 1Q18 launch.
The devices, created with the company's 3D-printed biomaterial, can offer structural support in deficient bone, and are indicated for use with GMK...
Medacta received FDA 510(k) clearance and completed first knee revision procedures with 3DMetal™ Tibial Cones. The cones—and Medacta’s recently-announced shoulder system—are slated for 1Q18 launch.
The devices, created with the company’s 3D-printed biomaterial, can offer structural support in deficient bone, and are indicated for use with GMK Revision and GMK Hinge knees as well as the tibial extension stems and offset.
Copy to clipboard 
